Maison de Solenn Maison des Adolescents, Cochin Hospital
Paris, IDF, 75014, France
Location status: Recruiting
Location contact
Marie Rose Moro, MD, PhD
CONTACT
Maude Ludot-Grégoire, MD
PRINCIPAL_INVESTIGATOR
Sophie Wery
CONTACT
NCT Number: NCT06211517
The purpose of this study is to access to the experiences of adolescents, their parents and healthcare professionals regarding psychotropic drugs in anorexia nervosa.
No preconceived ideas (according to qualitative methods) but a question: what are the participants' perceptions and experiences of psychotropic drugs in anorexia nervosa? In an adolescent medicine department.
Interested in participating?
Request Info12 year and older
All sexes
Observational
Paris, IDF, 75014, France
Location status: Recruiting
Marie Rose Moro, MD, PhD
CONTACT
Maude Ludot-Grégoire, MD
PRINCIPAL_INVESTIGATOR
Sophie Wery
CONTACT
Psychotropic prescription is common to adolescents suffering from anorexia nervosa. A first qualitative study (E3A Protocol "Experience of adolescents with anorexia nervosa toward antidepressants") looked at the experience of antidepressants among 15 adolescents suffering from anorexia nervosa. Analysis of the interviews identified two meta-themes:
Nine adolescents (out of 15) were also taking an atypical antipsychotic (APA) often prescribed in case of anorexia nervosa resistance.
The need to share with family about the proposal of antidepressant and the effects perceived through the eyes of others (including parent's eyes) lead us to take an interest in parents perceptions.
Two decisive periods were identified: What do healthcare professionals think about psychotropic treatments for anorexia nervosa in adolescence? How do they propose treatment?
Interviewing teenagers, their parents as well as healthcare professionals, will enable to access to the complexity of representations and experiences of these psychotropic drugs in anorexia nervosa.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Adolescents :
Parents of adolescents suffering from anorexia nervosa for whom a psychotropic drug has been prescribed and whose adolescents meet inclusion criteria
Healthcare Professionals working with adolescents suffering from eating disorders
Exclusion criteria
Adolescents :
Semi-structured interviews with visual mediations / An hour-long interview
Other names: Qualitative interviews
Semi-structured interviews
Other names: Qualitative interviews
Time frame: Day of inclusion
Themes describing adolescent experiences regarding psychotropic drugs in anorexia nervosa - Emergence of themes describing participants' experience from analysis of qualitative interviews (with Interpretative Phenomenology Analysis methodology)
Time frame: Day of inclusion
Themes describing parents experiences regarding psychotropic drugs for their children suffering from anorexia nervosa - Emergence of themes describing participants' experience from analysis of qualitative interviews (with Interpretative Phenomenology Analysis methodology)
Time frame: Day of inclusion
Themes describing healthcare professionals experiences regarding psychotropic drugs for adolescents suffering from anorexia nervosa - Emergence of themes describing participants' experience from analysis of qualitative interviews (with Interpretative Phenomenology Analysis methodology)
Contact information is provided by the study sponsor or research team.
Marie Benhammani-Godard
CONTACT
Maude Ludot-Gregoire, MD, psychiatrist
CONTACT
Assistance Publique - Hôpitaux de Paris
Other
Subjective Experience of Psychotropic Drugs Among Adolescents (Their Parents and Professionals) With Anorexia Nervosa
Acronym: E3P
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07600671
Anorexia Nervosa, Binge Eating Disorder
Lebanon, New Hampshire, United States
View Trial DetailsNCT05918835
Anorexia Nervosa, Feeding and Eating Disorders
New York, United States
View Trial DetailsNCT06594913
Anorexia Nervosa, Avoidant Restrictive Food Intake Disorder
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05763849
Anorexia Nervosa, Feeding and Eating Disorders
New York, United States
View Trial Details